tiprankstipranks
PremiumCompany AnnouncementsFractyl Health Reports Q3 2024 Financial Performance
3M ago
Premium
Company Announcements
Fractyl Health Unveils Promising Gene Therapy Data
3M ago
Fractyl Health presented new analysis of Revita studies at ObesityWeek 2024
Premium
The Fly
Fractyl Health presented new analysis of Revita studies at ObesityWeek 2024
3M ago
B. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
PremiumThe FlyB. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
7M ago
Fractyl Health price target lowered to $22 from $26 at BofA
Premium
The Fly
Fractyl Health price target lowered to $22 from $26 at BofA
7M ago
Premium
Company Announcements
Fractyl Health Updates Clinical Studies and Corporate Slides
7M ago
Fractyl Health reports Q4 EPS ($11.18) vs ($7.39) last year
PremiumThe FlyFractyl Health reports Q4 EPS ($11.18) vs ($7.39) last year
10M ago
Premium
Company Announcements
Fractyl Health Gains FDA Nod to Investigate Revita Device
10M ago
Fractyl Health receives FDA IDE approval for Revita Remain-1 pivotal study
Premium
The Fly
Fractyl Health receives FDA IDE approval for Revita Remain-1 pivotal study
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100